Life Sciences

The mission of HS Life Sciences is to provide a forum to review and discuss what is now possible in the industry.

Welcome to HS Life Sciences
Display Name
HS Life Sciences
Banner Image
Image

Kasra Shakeri-Nejad received his MD from the Charité, Faculty of Medicine of the Humboldt University Berlin and completed his Doctoral Thesis at the Charité Berlin in the Department of Neurosurgery. He received his advanced medical training in Neurology and holds a board certification as Medical Expert in Clinical Pharmacology. 

Complimentary Webinar

Health Literacy Register now >

Thursday June 15, 2023 - 9AM PDT / 12PM EDT / 5PM BST / 6PM CEST

Health literacy has two sides. For the patient, their level of health literacy defines how they can obtain, process, and understand health information and services needed to make appropriate health decisions.

Professor Anthony O'Hagan is an Emeritus Professor of Statistics at the University of Sheffield, UK.  A major strand of his research has been the elicitation of expert knowledge.  With Professor Jeremy Oakley (University of Sheffield), he developed the Sheffield Elicitation Framework (SHELF), now in version 4.  He has provided consultancy, training, and practical elicitations for several organisations in diverse sectors, including GlaxoSmithKline, Swiss Re and the European Food Safety Authority.

Getting the Big ‘Go – No Go’ Decisions Right: Harnessing the Power of Expert Knowledge Elicitation

What Expert Knowledge Elicitation is
When to use it
How to do it well

⠀⠀⠀
Big decisions typically come with big risks. Expert Elicitation can reduce the risks of making the wrong call. This is a webinar on when to do Expert Elicitation and how to do Expert Elicitation.

The need:

Brian is a board-certified MD/PhD Pediatric Neurologist who has served in roles as a clinician, academic researcher, and vice-president in top biotech and healthcare companies. He has extensive experience leading teams of teams, coordinating and uniting large groups of people to successfully develop new pediatric medicines, including gene therapies.

Brian is a board-certified MD/PhD Pediatric Neurologist who has served in roles as a clinician, academic researcher, and vice-president in top biotech and healthcare companies. He has extensive experience leading teams of teams, coordinating and uniting large groups of people to successfully develop new pediatric medicines, including gene therapies.

Darcy has responsibility and oversight for clinical operations service delivery, including patient engagement, clinical operations, data management, and nursing solutions, and she has more than 20 years of experience bridging clinical operational expertise and strategic corporate development initiatives with a passion for innovative and decentralized clinical trial execution.

Darcy has responsibility and oversight for clinical operations service delivery, including patient engagement, clinical operations, data management, and nursing solutions, and she has more than 20 years of experience bridging clinical operational expertise and strategic corporate development initiatives with a passion for innovative and decentralized clinical trial execution.

Sam leads a team focused on modernising and adapting clinical trials and pharmaceutical operations. This includes areas such as adding technology to trials to bring better and more meaningful data; how we find and interact with patients in clinical research; how trials are run and where – in order to increase access and representation; as well as other aspects of patient centricity and trial decentralization.